Patents by Inventor Nina Ma

Nina Ma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 5-MEMBERED HETEROARYLAMINOSULFONAMIDES FOR TREATING CONDITIONS MEDIATED BY DEFICIENT CFTR ACTIVITY
    Publication number: 20240002374
    Abstract: The invention relates to heteroaryl compounds, pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating diseases and conditions mediated by deficient CFTR activity, in particular cystic fibrosis.
    Type: Application
    Filed: May 11, 2022
    Publication date: January 4, 2024
    Inventors: Junkai Liao, Mark Munson, Zhongli Gao, Gregory Hurlbut, Sylvie Baltzer, Bertrand Vivet, Brian Freed, Hans Peter Nestler, Helen Yeoman, Ingrid Mechin, Martin Smrcina, Nina Ma, Sylvain Lebreton, Ryan Hartung, William Wire, Sukanthini Thurairatnam
  • ARYLAMIDES AND METHODS OF USE THEREOF
    Publication number: 20230159439
    Abstract: The present disclosure relates to heterocyclic compounds, pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating diseases and conditions mediated by deficient CFTR activity, in particular cystic fibrosis.
    Type: Application
    Filed: June 3, 2022
    Publication date: May 25, 2023
    Inventors: Junkai Liao, Mark Munson, Zhongli Gao, Gregory Hurlbut, Hans Peter Nestler, Ingrid Mechin, Joseph Kim, Martin Smrcina, Nina Ma, Ronghua Li, Ryan Hartung, William Bock, Bertrand Vivet
  • ARYLAMIDES AND METHODS OF USE THEREOF
    Publication number: 20230159438
    Abstract: The present disclosure relates to heterocyclic compounds, pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating diseases and conditions mediated by deficient CFTR activity, in particular cystic fibrosis.
    Type: Application
    Filed: June 3, 2022
    Publication date: May 25, 2023
    Inventors: Junkai Liao, Mark Munson, Zhongli Gao, Gregory Hurlbut, Hans Peter Nestler, Helen Yeoman, Martin Smrcina, Ronghua Li, Ryan Hartung, William Wire, Bertrand Vivet, Nina Ma
  • METHODS OF CELLULAR REPROGRAMMING
    Publication number: 20170121687
    Abstract: The present invention relates to a method for reprogramming a first cell type to an intermediate cell of a second cell type comprising the step of contacting the first cell with a first agent to modulate an integrin profile in the first cell type to provide an intermediate cell of the second cell type. The present invention also relates to a reprogrammed cell obtained by the method of the invention, a kit for reprogramming a first cell type to a second cell type as well as methods for treating a patient in need of cell based therapy, tissue replacement and cancer therapy.
    Type: Application
    Filed: April 23, 2015
    Publication date: May 4, 2017
    Inventors: Andrew Chwee Aun WAN, Jia Kai LIM, Vivian Yujing LIM, Nina MA, Siti Thaharah MOHAMED
  • 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them
    Patent number: 8163768
    Abstract: This invention relates to compounds of formula (I) to processes for the preparation of such compounds, to pharmaceutical compositions comprising such compounds, and to methods of treatment comprising administering of such compounds.
    Type: Grant
    Filed: January 15, 2008
    Date of Patent: April 24, 2012
    Assignee: Aventis Pharma S.A..
    Inventors: Jacques Mauger, Anil Nair, Nina Ma, Kirsten Bjergarde, Bruno Filoche-Romme, Odile Angouillant-Boniface, Serge Mignani, Jean-Christophe Carry, Francois Clerc, Herve Minoux, Laurent Schio, Cecile Combeau
  • 1,4-Dihydropyridine-Fused Heterocycles, Process for Preparing the Same, Use and Compositions Containing Them
    Publication number: 20080261969
    Abstract: This invention relates to compounds of formula (I) to processes for the preparation of such compounds, to pharmaceutical compositions comprising such compounds, and to methods of treatment comprising administering of such compounds.
    Type: Application
    Filed: January 15, 2008
    Publication date: October 23, 2008
    Applicant: AVENTIS PHARMA S.A.
    Inventors: Jacques MAUGER, Anil NAIR, Nina MA, Kirsten BJERGARDE, Bruno FILOCHE-ROMME, Odile ANGOUILLANT-BONIFACE, Serge MIGNANI, Jean-Christophe CARRY, Francois CLERC, Herve MINOUX, Laurent SCHIO, Cecile COMBEAU